Head-to-head · WeighScore
Direct Meds vs Rex MD
By GLP-1 ScorecardUpdated
Score comparison
Direct Meds has the higher recorded score — 77.6/100 to 70.2/100.
Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.
Before you choose
Before comparing the headline prices, the Direct Meds review and the Rex MD review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, Direct Meds vs Rixa Health and FORM (by GBY) vs Rex MD compare each of them with another graded program, and the list of alternatives to Direct Meds ranks the programs closest to Direct Meds on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Direct Meds | Rex MD |
|---|---|---|
| WeighScore | 77.6/100 | 70.2/100 |
| Grade | C+ | C |
| Site position | #33 | #119 |
| Semaglutide | $249/30 days sublingual · $297/mo injectable | $349/mo (starting price, brand-name Wegovy pill with provider care) |
| Tirzepatide | $299/30 days sublingual · $399/mo injectable | Not disclosed (brand Zepbound access listed) |
| Coverage | Not publicly listed | All 50 states (platform claim; confirm treatment availability) |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Yes | Yes |
Site position #33 · C+
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Strengths
- Injection and sublingual preparations have separately published prices
- Pricing page advertises medication, evaluation, supplies, shipping and nurse access
- Both semaglutide and tirzepatide are listed
- Checked semaglutide campaign states $147 initially, then $297 monthly
What to consider
- Compounded preparations are not FDA-approved products or assumed equivalent across routes
- No-subscription FAQ wording conflicts with the agreement's 30-day recurring charges
- Renewal cancellation requires 48-hour notice; initial-order cancellation has a separate conditional 24-hour window
- Assigned prescribing practice, dispensing pharmacy and selected longer-plan total need confirmation
- Checked campaign excludes Mississippi and Louisiana; confirm state eligibility
Site position #119 · C
Strengths
- Current Wegovy pill offer includes medication and provider care
- Advertises the same pill price across its listed titration strengths
- Wegovy pen and Zepbound access are also listed
- FAQ describes overnight shipping for weight-management prescriptions
What to consider
- Does not accept insurance
- FAQ also describes a separate $75 starting program price with variable medication costs
- Current Wegovy pen and Zepbound totals were not verified
- Automatic-renewal terms require attention; prescription medications are nonreturnable and nonrefundable
Featured provider
Direct Meds
Direct Meds scores 77.6/100 (C+). Direct Meds prices compounded injections and sublingual bottles separately; compare the renewal charge and early cancellation cutoff before choosing a plan.
Commercial relationships affect this placement. The score comparison above is separate.
FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.